GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for the investigational once-daily LAMA/LABA combination medicine, umeclidinium bromide (UMEC/VI), to treat chronic obstructive pulmonary disease (COPD) ...
Tags: GlaxoSmithKline, regulatory application, Medicine, FDA
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
Department of Veterans Affairs has granted approval to Breathe Technologies' Non-Invasive Open Ventilation (NIOV) system, designed to treat chronic obstructive pulmonary disease. FDA-cleared NIOV system, which will be added to the ...
Tags: Breathe NIOV System, chronic obstructive pulmonary disease
Ceretec has launched a nitric-oxide (NO) lung diffusion gas mixture, NO-Diff, for use in membrane diffusing capacity (DLNO) testing in pulmonary function laboratories in the US. The gas product, classified as Class 1 medical device by ...
Tags: medical device, lung diffusion gas mixture, clinical technology
MedQIA, a provider of computer vision systems for automated image analysis and measurement, has developed a software toolkit of image analysis routines. The software toolkit, which forms basis of an imaging biomarker information system ...
Tags: MedQIA, computer vision systems, imaging biomarker information system
The US Food and Drug Administration (FDA) has granted approval to Pulmonx to commence an investigational device exemption (IDE) pivotal clinical study of its Zephyr Endobronchial Valve (EBV) therapy, designed to treat emphysema. The ...
Tags: FDA, Endobronchial Valve therapy, emphysema, Zephyr EBV therapy
DISCLAIMER: UBM Canon is the parent company of Packaging Digest. The 12th edition of Pharmapack Europe, Feb. 13-14, 2013, Grande Halle de la Villette (Paris), will welcome more than 3,000 visitors from all over the globe and around 280 ...
Tags: UBM Canon, Packaging, Pharma packaging
GeNO has obtained a clearance for its inhaled nitric oxide (NO) delivery system, GeNOsyl MV-1000, from the US Food and Drug Administration (FDA). GeNOsyl MV-1000 system, which incorporates a primary delivery system, a backup system, ...
Tags: FDA, inhaled nitric oxide delivery system, clinical product, GeNO
GeNO has received four additional US patents for its proprietary nitric oxide (NO) generation chemistry and delivery technology. The patent No. 8,211,368 describes the conversion of nitrogen dioxide (NO2) to NO where NO2 is stored as ...
Tags: US patent, clinical technology, clinical research, GeNO
Theravance has commenced Phase 2b study desined to evaluate varying doses of TD-4208 in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Theravance leveraged its multivalent approach of drug design to ...
Tags: drug, long-acting medicines, long-acting muscarinic antagonist
Forest Laboratories and Almirall have announced the commercial availability of anticholinergic agent Tudorza Pressair in 400mcg dose strength, in the US pharmacies. The FDA approved long-acting anticholinergic was indicated for the ...
Tags: anticholinergic agent, pharmacies, multidose, Almirall, medicine
Horizon Pharma has commercially launched Rayos (prednisone) delayed release tablets in the US. Rayos is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma ...
Tags: Horizon Pharma, Rayos, rheumatoid arthritis
The US Patent and Trademark Office (USPTO) has granted a patent to Pearl Therapeutics' co-suspension formulation technology for inhaled combinations. The Patent No. 8,324,266 covers methods for treating pulmonary disease using Pearl's ...
The European Union has granted CE mark approval to BiO2 Medical's inferior vena cava(IVC)filter for use in critically ill patients who are at increased risk of pulmonary embolism and temporarily contraindicated for anticoagulation therapy. ...
Tags: European Union, CE mark approval, BiO2 Medical, IVC filter
Mylan has signed a settlement and license agreements with Shionogi and CIMA Labs regarding Prednisolone sodium phosphate orally disintegrating tablets (ODT), known generically as Orapred ODT. Mylan said that following the settlement ...